Table 3.
Description of inflammatory markers at each visit.
| Visit 1 | Visit 2 | Visit 3 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomarkers | n | Geometric mean | Median (25th, 75th percentile) | n | Geometric mean | Median (25th, 75th percentile) | n | Geometric mean | Median (25th, 75th percentile) | |||||||||
| BNP (pg/mL) | 100 | 112.48 | 103.5 (44.3, 284.5) | 92 | 97.71 | 90.4 (40.9, 238) | 93 | 106.54 | 110 (46.7, 223) | |||||||||
| CRP (mg/L) | 81 | 2.81 | 3.1 (0.94, 6.89) | 76 | 2.17 | 1.84 (0.92, 5.60) | 73 | 2.58 | 1.88 (0.93, 7.86) | |||||||||
| Endothelin-1 (pg/mL)a | 90 | 2.31 | 2.32 (1.80, 2.90) | 8b | 1.813 | 1.77 (1.56, 2.03) | 90 | 2.42 | 2.39 (1.94, 2.92) | |||||||||
| TNF (pg/mL)a | 95 | 1.70 | 1.65 (1.11, 2.07) | 89 | 1.65 | 1.59 (1.14, 2.19) | 86 | 1.62 | 1.47 (1.19, 2.02) | |||||||||
| aOutlier observations are included. bEndothelin-1 measures typically occurred at visits 1 and 3, but 8 samples were analyzed at visit 2 when visit 1 or visit 3 data were unavailable. | ||||||||||||||||||